Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [2];  [3];  [2];  [2];  [1]
  1. Technische Universitaet Berlin, Institut fuer Chemie, FG Biochemie und Molekulare Biologie, 10587 Berlin (Germany)
  2. Robert Koch-Institut, FG 16, 13353 Berlin (Germany)
  3. Robert Koch-Institut, ZBS4, 13353 Berlin (Germany)

This is First report on the antifungal effects of the new glycolipopeptide hassallidin A. Due to related molecular structure moieties between hassallidin A and the established antifungal drug caspofungin we assumed parallels in the effects on cell viability. Therefore we compared hassallidin A with caspofungin by antifungal susceptibility testing and by analysing the genome-wide transcriptional profile of Candida albicans. Furthermore, we examined modifications in ultracellular structure due to hassallidin A treatment by electron microscopy. Hassallidin A was found to be fungicidal against all tested Candida species and Cryptococcus neoformans isolates. MICs ranged from 4 to 8 {mu}g/ml, independently from the species. Electron microscopy revealed noticeable ultrastructural changes in C. albicans cells exposed to hassallidin A. Comparing the transcriptional profile of C. albicans cells treated with hassallidin A to that of cells exposed to caspofungin, only 20 genes were found to be similarly up- or down-regulated in both assays, while 227 genes were up- or down-regulated induced by hassallidin A specifically. Genes up-regulated in cells exposed to hassallidin A included metabolic and mitotic genes, while genes involved in DNA repair, vesicle docking, and membrane fusion were down-regulated. In summary, our data suggest that, although hassallidin A and caspofungin have similar structures, however, the effects on susceptibility and transcriptional response to yeasts seem to be different.

OSTI ID:
20854529
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 349; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

Synthesis, in vitro antifungal evaluation and docking studies of novel derivatives of imidazoles and benzimidazoles
Journal Article · Sun Sep 01 00:00:00 EDT 2019 · Medicinal Chemistry Research (Print) · OSTI ID:22936179

Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2
Journal Article · Mon Jan 06 23:00:00 EST 2020 · Cell Chemical Biology · OSTI ID:1834882

Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents
Journal Article · Thu Sep 19 00:00:00 EDT 2019 · Nature Communications · OSTI ID:1573396